Back
Innate Pharma SA Quote, Financials, Valuation and Earnings
Sell
36
IPHA
Innate Pharma SA
Last Price:
2.61
Seasonality Move:
-5.75%
7 Day Trial
ALL ACCESS PASS
$
7
Innate Pharma SA Price Quote
$2.61
-0.13 (-5.09%)
(Updated: June 1, 2024 at 6:23 AM ET)
Innate Pharma SA Key Stats
Sell
36
Innate Pharma SA (IPHA)
is a Sell
Day range:
$2.61 - $2.80
52-week range:
$1.81 - $3.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.91
P/B ratio:
3.86%
Volume:
22.1K
Avg. volume:
7.5K
1-year change:
-6.8%
Market cap:
$221.5M
Revenue:
$56.2M
EPS:
$-0.1
How Much Does Innate Pharma SA Make?
-
How Much Are Innate Pharma SA's Sales Annually?
IPHA Revenues are $56.2M -
How Much Profit Does Innate Pharma SA's Make A Year?
IPHA net income is -$8.2M
Is Innate Pharma SA Growing As A Company?
Data Unavailable
Innate Pharma SA Stock Price Performance
-
Did Innate Pharma SA Stock Go Up Last Month?
Innate Pharma SA share price went up by 18.61% last month -
Did IPHA's Share Price Rise Over The Last Year?
IPHA share price fell by -6.8% over the past 1 year
What Is Innate Pharma SA 52-Week High & Low?
-
What Is Innate Pharma SA’s 52-Week High Share Price?
Innate Pharma SA has traded as high as $3.57 over the past 52 weeks -
What Is Innate Pharma SA’s 52-Week Low Share Price?
Innate Pharma SA has traded as low as $1.81 over the past 52 weeks
Innate Pharma SA Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Innate Pharma SA?
-
How Much Debt Does Innate Pharma SA Have?
Total long term debt quarterly is $43.2M -
How Much Cash Does Innate Pharma SA Have?
Cash and short term investments quarterly total is $102.2M -
What Is Innate Pharma SA’s Book Value Per Share?
Book value per share is 0.71
Is Innate Pharma SA Cash Flow Positive?
-
What Is IPHA Cash Flow From Operations?
Cash flow from operations (TTM) is -$35.2M -
What Is Innate Pharma SA’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.1M -
What Is Innate Pharma SA’s Cash Flow From Investing?
Cash flow from investing (TTM) is $22.2M
Innate Pharma SA Return On Invested Capital
-
Is Management Doing A Good Job?
IPHA return on invested capital is -7.88% -
What Is Innate Pharma SA Return On Assets?
ROA measures how assets are converting to revenues and is -3.79% -
What Is IPHA Return On Equity?
ROE is a measure of profitability and is -13.68%
Innate Pharma SA Earnings Date & Stock Price
-
What Is Innate Pharma SA's Stock Price Today?
A single share of IPHA can be purchased today for 2.74 -
What Is Innate Pharma SA’s Stock Symbol?
Innate Pharma SA trades on the nasdaq under the ticker symbol: IPHA -
When Is Innate Pharma SA’s Next Earnings Date?
The next quarterly earnings date for Innate Pharma SA is scheduled on September 12, 2024 -
When Is IPHA's next ex-dividend date?
Innate Pharma SA's next ex-dividend date is June 3, 2024 -
How To Buy Innate Pharma SA Stock?
You can buy Innate Pharma SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Innate Pharma SA Competitors
-
Who Are Innate Pharma SA's Competitors?
Below is a list of companies who compete with Innate Pharma SA or are related in some way:
Innate Pharma SA Dividend Yield
Data Unavailable
Innate Pharma SA Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 7.45 |
| Upside from Last Price: | 171.9% |